久久亚洲av成人出白浆,日日添夜夜添夜夜添爱欧美,真人视频gif无码专区,日日操夜夜操狠狠操麻豆

產(chǎn)品與服務(wù)
聯(lián)系我們
公司名稱:廣州健侖生物科技有限公司
地址:廣東省廣州市番禺區(qū)石樓鎮(zhèn)清華科技園創(chuàng)啟路63號A2棟101
郵編:510660
聯(lián)系人: 楊永漢
傳真:86-020-32206070
E-mail: service@jianlun.com
產(chǎn)品展示
您現(xiàn)在的位置:首頁 > 產(chǎn)品中心 > 檢測試劑 > 尼古丁檢測試劑 > 40T診斷違禁品試劑杯-MOMC
40T診斷違禁品試劑杯-MOMC

40T診斷違禁品試劑杯-MOMC

型    號:
報    價:
分享到:

40T診斷違禁品試劑杯-MOMC:我司同時有bzo - bar - coc - thc met - - opi - oxy - mdma - cfp - amp - xtc – bat多聯(lián)檢測卡(膠體金法)

  • 產(chǎn)品描述

                                  40T診斷違禁品試劑杯-MOMC                                 

INTENDED USE

Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

 

Parameter

Calibrator

Cut-off(ng/mL)

THC

11-nor-D9-THC-9-COOH

50 ng/ml

COC

Benzoylecgonine

300 ng/ml

PCP

Phencyclidine

25 ng/ml

OPI

Morphine

2000 ng/ml

MET

Methamphetamine

1000 ng/ml

MTD

Methadone

300 ng/ml

AMP

Amphetamine

1000 ng/ml

BAR

Secobarbital

300 ng/ml

BZO

Oxazepam

300 ng/ml

TCA

Nortriptyline

1000 ng/ml

MDMA

3,4-Methylenediioxy-MET

500 ng/ml

BUP

BUP-3-D-Glucuronide

10 ng/ml

EDDP

EDDP

100 ng/ml

OPI/MOR

Morphine

300 ng/ml

KET

Ketamine 

1,000ng/ml

TML

Cis-Tramadol 

100ng/ml

OXY

Oxycodone

100ng/ml

PPX

Propoxyphene

300ng/ml

K2

JWH-073/JWH-01

50 ng/ml

FYL

*

200 ng/ml

COT

Cotinine

200 ng/ml

ALC

Alcohol

 

 

The test is used to obtain visual qualitative result and is intended for health care professionals use including professionals at point of care sites to assist in the determination of drug compliance. It is not intended for over the counter sale to non-professionals.

This assay provided only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC/MS) or Liquid Chromatography/ Mass Spectrometry (LC/MS) are the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

INTRODUCTION

Urine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method for screening urine for drugs of abuse.

The DOA Panels are based on the principle of the highly specific immunochemical reactions of antigens and antibodies, which are used for the analysis of specific compounds in human urine. The DOA Screen Panels are rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid, Benzoylecgonine, Phencyclidine, Morphine, Methadone, Methamphetamine, Amphetamine, Barbiturates, Oxazepam, Nortriptyline, MDMA, ,Ketamine,Buprenorphine-3-D-Glucuronide, Tramadol and EDDP in urine. The length of time following drug use for which a positive result may occur is dependent upon several factors including the frequency and amount of drug, metabolic rate, excretion rate, drug half-life, and the drug user’s age, weight, activity and diet.

PRINCIPLE

The DOA Panels are one-step immunoassay in which chemically labeled drugs (drug-protein conjugates) compete for limited antibody binding sites with drugs which may be present in urine. The test device contains membrane strips which are pre-coated with drug-protein conjugates on the test band(s). Each strip, the drug antibody-colloidal gold conjugate pad is placed at one end of the membrane. In the absence of drug in the urine, the solution of the colored antibody-colloidal gold conjugate move along with the sample solution upward chromatographically by capillary action across the membrane to the immobilized drug-protein conjugate zone on the test band region. The colored antibody-gold conjugate then attach to the drug-protein conjugates to form visible lines as the antibody complex with the drug conjugate. Therefore, the formation of the visible precipitant in the test zone occurs when the test urine is negative for the drug. When the drug is present in the urine, the drug/metabolite antigen competes with drug-protein conjugate on the test band region for the limited antibody.  When a sufficient concentration of the drug is present, it will fill the limited antibody binding sites. This will prevent attachment of the colored antibody (drug-protein conjugate)-colloidal gold conjugate to the drug-protein conjugate zone on the test band region. Therefore, absence of the color band on the test region indicates a positive result.

A control band with a different antigen/antibody reaction is added to the immunochromatographic membrane strip at the control region (C) to indicate that the test has performed properly. This control line should always appear regardless of the presence of drug or metabolite. If the control line does not appear the test device should be discarded. 

添加掃一掃二維碼:

【公司名稱】 廣州健侖生物科技有限公司

【市場部】       楊永漢
【】 
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室

廣州健侖生物科技有限公司(www.trqcyp.com) 熱門產(chǎn)品:喹諾酮類檢測試劑盒,西尼羅河檢測試劑,基孔肯雅熱試劑,寨卡檢測試劑,疫病核酸試劑
地址:廣東省廣州市番禺區(qū)石樓鎮(zhèn)清華科技園創(chuàng)啟路63號A2棟101 Email:service@jianlun.com
ICP備:粵ICP備11063766號 GoogleSitemap 技術(shù)支持:化工儀器網(wǎng) 管理登陸 返回首頁
a片在线观看| 老色69久久九九精品高潮| 扒开胸罩疯狂揉搓奶头| 日韩精品无码区免费专区| 成人无码H免费动漫在线观看| A片做爰片仑理片免费看| 亚洲 欧美 叧类人妖| 亚洲欧洲精品饰品推荐有限公司| 一面亲上边一面膜下边| 国语第一次处破女| 国产一起色一起爱| 国产女人18毛片水真多18精品| a片粗大的内捧猛烈进出男男小说| 中国丰满人妻videoshd| 国产精品一区二区AV不卡 | 女朋友闺蜜奶好大下面好紧| 午夜精品乱人伦小说区| 精品无码久久久久久久久水蜜桃| 性欧美残忍折磨猛交无码视频| 精品久久久无码人妻字幂| a片在线观看| 扒开粉嫩小泬舌头伸进去视频| 公与憩止痒小说400章| а√最新版地址在线天堂| 成人av无码一区二区三区| 99精品福利国产在线导航| 99国产精品久久久久久久成人| 国产妇女馒头高清泬20p多| 大地影院HD免费高清完整版 | 淑娟两腿间又痒了| 欧美特黄a级高清免费大片a片| 国产成人午夜精品一区二区三区| 人妻无码视频一区二区三区| 99久久国产精品人妻无码| 日本亚洲色大成网站www久久| 搡老女人老熟妇HHD| 驯服人妻HD中字日本| 中文无码亚洲色偷偷a片| 午夜不卡久久精品无码免费| 亚洲精品无码成人A片| 肉色欧美久久久久久久蜜桃|